CompaniesByCap
TSHA
Taysha Gene Therapies Inc. (TSHA)
NASDAQ · Healthcare

Taysha Gene Therapies Inc. PS Ratio 2020–2026

Current and historical P/S ratio for Taysha Gene Therapies Inc. (TSHA): market cap divided by trailing twelve-month revenue. As of March 31, 2026 it is 382.19.
From: 03/31/2024To: 03/31/2026
Stock Price
TTM Revenue
PS Ratio

Taysha Gene Therapies Inc. PS Ratio — FAQ

Taysha Gene Therapies Inc. (TSHA) ps ratio over the last 4 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TSHA's ps ratio history?

The chart and table above show Taysha Gene Therapies Inc.'s ps ratio by year and by quarter, including the growth rate.